DTIL
Precision BioSciences, Inc. - Common Stock (DTIL)
$58
About Precision BioSciences, Inc. - Common Stock (DTIL)
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.
Details
Daily high
$4.64
Daily low
$4.51
Price at open
$4.56
52 Week High
$13.32
52 Week Low
$3.61
Market cap
18.9M
Dividend yield
0.00%
Volume
20,202
Avg. volume
99,230
P/E ratio
-2.30
Precision BioSciences, Inc. - Common Stock News
Details
Daily high
$4.64
Daily low
$4.51
Price at open
$4.56
52 Week High
$13.32
52 Week Low
$3.61
Market cap
18.9M
Dividend yield
0.00%
Volume
20,202
Avg. volume
99,230
P/E ratio
-2.30